| Ab00846-2.3
| Anti-V(beta)3 TCR [JOVI.1]
| 200 ug
| Absolute Antibody
| FACS; IHC; IF; IP
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03037-10.3-BT
| Anti-VEGFR2 [D3-D3]
| 1 mg
| Absolute Antibody
| ELISA; IHC
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03838-23.0
| Anti-Hepatocyte growth factor [t8E4]
| 100 ug
| Absolute Antibody
| ELISA; inhibition; SPR; IP; Crystallization; WB; I
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03795-23.0
| Anti-APP [2C5]
| 100 ug
| Absolute Antibody
| ELISA; blocking
|
|
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| Ab00510-10.6-BT
| Anti-Vaginolysin [23A2]
| 1 mg
| Absolute Antibody
| ELISA; WB; Block
|
|
| Other
| Solicitar Precio
| Solicitar
|
| Ab03808-1.1-BT
| Anti-CTLA-4 [11.2.1]
| 1 mg
| Absolute Antibody
| in vivo
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03825-23.0
| Anti-EGFR [ML66]
| 100 ug
| Absolute Antibody
| Inhibition; FC; in vivo
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03810-23.0-BT
| Anti-VEGF-D [3A]
| 1 mg
| Absolute Antibody
| SPR
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03058-10.3
| Anti-VEGFR2 [IMC-1121B (Ramucirumab)]
| 200 ug
| Absolute Antibody
| FC; IHC; crystallography; in vitro; in vivo; thera
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03824-10.0-BT
| Anti-4Ig-B7H3 [8H9]
| 1 mg
| Absolute Antibody
| WB; therapeutic; in vivo; IHC; IP
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03843-23.0-BT
| Anti-Norfloxacin [mAb#nor155]
| 1 mg
| Absolute Antibody
|
|
|
| Other
| Solicitar Precio
| Solicitar
|
| Ab03058-10.29-BT
| Anti-VEGFR2 [IMC-1121B (Ramucirumab)]
| 500 ug
| Absolute Antibody
| FC; IHC; crystallography; in vitro; in vivo; thera
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03799-1.1-BT
| Anti-FZD7 [Fab-1219]
| 1 mg
| Absolute Antibody
| WB
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03845-1.1
| Anti-gp120 protein (CD4-binding domain) [559/64-D]
| 100 ug
| Absolute Antibody
| ELISA; Neutralization; blocking
|
|
| HIV-1
| Solicitar Precio
| Solicitar
|
| Ab03818-2.0
| Anti-mammalian sTnI [6G1]
| 100 ug
| Absolute Antibody
| WB; ELISA
|
|
| Horse; Pig; Cattle; Deer; Sheep
| Solicitar Precio
| Solicitar
|
| Ab03810-30.11
| Anti-VEGF-D [3A]
| 100 ug
| Absolute Antibody
| SPR
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03828-10.0-BT
| Anti-MERS-CoV Spike protein [2E6]
| 1 mg
| Absolute Antibody
| ELISA; NTRL; FC; SPR
|
|
| MERS Coronavirus
| Solicitar Precio
| Solicitar
|
| Ab00136-2.3
| Anti-V5 epitope tag [SV5-P-K]
| 200 ug
| Absolute Antibody
| ELISA; IF; IHC-Fr; IP; RIA; WB
|
|
| Paramyxovirus Simian Virus 5
| Solicitar Precio
| Solicitar
|
| Ab03845-1.1-BT
| Anti-gp120 protein (CD4-binding domain) [559/64-D]
| 1 mg
| Absolute Antibody
| ELISA; Neutralization; blocking
|
|
| HIV-1
| Solicitar Precio
| Solicitar
|
| Ab00715-10.29-BT
| Anti-VEGF [Bevacizumab]
| 500 ug
| Absolute Antibody
| ELISA; IP; WB; Block; FC
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03803-23.0
| Anti-ICOS ligand [Clone 325]
| 100 ug
| Absolute Antibody
| inhibit, Block, ELISA, FC
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03839-10.0
| Anti-Hepatocyte growth factor [t1E4]
| 100 ug
| Absolute Antibody
| ELISA; inhibition; IP; SPR
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03817-10.0
| Anti-Gn [Mab-3 (32A8-1)]
| 100 ug
| Absolute Antibody
| ELISA; Neutralization; in vivo
|
|
| Rift Valley fever virus
| Solicitar Precio
| Solicitar
|
| Ab03833-23.0-BT
| Anti-CD98 [8-34B]
| 1 mg
| Absolute Antibody
| Inhibition; in vivo; IHC; FACS; SPR
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03847-23.0-BT
| Anti-Norovirus GII.4 [12A11]
| 1 mg
| Absolute Antibody
| ELISA, blocking
|
|
| Norovirus
| Solicitar Precio
| Solicitar
|
| Ab03815-1.1
| Anti-Gn [Mab-1 (23A8-1)]
| 100 ug
| Absolute Antibody
| ELISA; Neutralization; in vivo
|
|
| Rift Valley fever virus
| Solicitar Precio
| Solicitar
|
| Ab03797-10.0
| Anti-HLA/EBNA1 [anti-HLA-A0201/EBNA1 antibody]
| 100 ug
| Absolute Antibody
| SPR; IHC; FC
|
|
| Epstein-Barr virus
| Solicitar Precio
| Solicitar
|
| Ab03796-23.0-BT
| Anti-APP [2F9]
| 1 mg
| Absolute Antibody
| ELISA; blocking
|
|
| Human, Mouse
| Solicitar Precio
| Solicitar
|
| Ab03783-23.0-BT
| Anti-Benzopyrene [22F12]
| 1 mg
| Absolute Antibody
| ELISA
|
|
| Other
| Solicitar Precio
| Solicitar
|
| Ab03841-23.0-BT
| Anti-Envelope protein E [6B6C-1]
| 1 mg
| Absolute Antibody
| ELISA; WB
|
|
| St. louis encephalitis virus (SLEV); Dengue virus
| Solicitar Precio
| Solicitar
|
| Ab03812-10.0
| Anti-cytochrome C [R1D3]
| 100 ug
| Absolute Antibody
| ICC
|
|
| Mouse
| Solicitar Precio
| Solicitar
|
| Ab03837-10.0-BT
| Anti-Integrin alpha 6 beta 1 [TS2/16]
| 1 mg
| Absolute Antibody
| Cristallography; FC; IP; in vivo; in vitro
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03808-1.1
| Anti-CTLA-4 [11.2.1]
| 100 ug
| Absolute Antibody
| in vivo
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03817-1.1
| Anti-Gn [Mab-3 (32A8-1)]
| 100 ug
| Absolute Antibody
| ELISA; Neutralization; in vivo
|
|
| Rift Valley fever virus
| Solicitar Precio
| Solicitar
|
| Ab03809-23.0-BT
| Anti-VEGF-D; AR74 [1A]
| 1 mg
| Absolute Antibody
| ELISA; SPR
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03058-3.3-BT
| Anti-VEGFR2 [IMC-1121B (Ramucirumab)]
| 1 mg
| Absolute Antibody
| FC; IHC; crystallography; in vitro; in vivo; thera
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03790-23.0
| Anti-HCV E1 [5D2]
| 100 ug
| Absolute Antibody
| ELISA; Neutralizing; SPR
|
|
| Hepatitis C virus
| Solicitar Precio
| Solicitar
|
| Ab03797-10.0-BT
| Anti-HLA/EBNA1 [anti-HLA-A0201/EBNA1 antibody]
| 1 mg
| Absolute Antibody
| SPR; IHC; FC
|
|
| Epstein-Barr virus
| Solicitar Precio
| Solicitar
|
| Ab03843-23.0
| Anti-Norfloxacin [mAb#nor155]
| 100 ug
| Absolute Antibody
|
|
|
| Other
| Solicitar Precio
| Solicitar
|
| Ab03784-23.0-BT
| Anti-PD-L1 [BT613]
| 1 mg
| Absolute Antibody
| SPR; blocking; in vitro; inhibition; in vivo
|
|
| Human; Mouse
| Solicitar Precio
| Solicitar
|
| Ab03678-30.11-BT
| Anti-Usutu virus envelop protein E [A9]
| 500 ug
| Absolute Antibody
| ELISA; WB
|
|
| Usutu virus (USUV)
| Solicitar Precio
| Solicitar
|
| Ab03828-23.0-BT
| Anti-MERS-CoV Spike protein [2E6]
| 1 mg
| Absolute Antibody
| ELISA; NTRL; FC; SPR
|
|
| MERS Coronavirus
| Solicitar Precio
| Solicitar
|
| Ab03816-23.0-BT
| Anti-Gn [Mab-2 (23B5-1)]
| 1 mg
| Absolute Antibody
| ELISA; Neutralization; in vivo
|
|
| Rift Valley fever virus
| Solicitar Precio
| Solicitar
|
| Ab00511-10.6
| Anti-Vaginolysin [9B4]
| 200 ug
| Absolute Antibody
| ELISA; WB; Block
|
|
| Other
| Solicitar Precio
| Solicitar
|
| Ab03820-10.0-BT
| Anti-SERPINA1 [SERPINA1-1]
| 1 mg
| Absolute Antibody
| WB; IHC; ELISA; Inhibition
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03058-10.3-BT
| Anti-VEGFR2 [IMC-1121B (Ramucirumab)]
| 1 mg
| Absolute Antibody
| FC; IHC; crystallography; in vitro; in vivo; thera
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03785-23.0-BT
| Anti-PD-L1 [CA782]
| 1 mg
| Absolute Antibody
| ELISA; SPR
|
|
| Mouse
| Solicitar Precio
| Solicitar
|
| Ab03809-30.11
| Anti-VEGF-D; AR74 [1A]
| 100 ug
| Absolute Antibody
| ELISA; SPR
|
|
| Human
| Solicitar Precio
| Solicitar
|
| Ab03842-1.1
| Anti-Hendra and Nipah virus F [1F5]
| 100 ug
| Absolute Antibody
| Functional assay; Neutralize
|
|
| Hendra henipavirus (Hendra virus, HeV), Nipah he
| Solicitar Precio
| Solicitar
|
| Ab03800-10.0-BT
| Anti-FZD7 [Fab-1791]
| 1 mg
| Absolute Antibody
| WB; in vitro; FC; IHC; blocking
|
|
| Human
| Solicitar Precio
| Solicitar
|